Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Journal of Internal Medicine|March 28, 2022
Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs)Cristina Gálvez, Víctor Urrea, Maria Del Carmen Garcia-Guerrero, et al.
Current HIV Research|November 26, 2009
HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, SpainBeatriz Mothe, Iñaki Perez, Pere Domingo, et al.
Journal of the International AIDS Society|August 19, 2024
The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysisMing Jie Lee, Miles Eason, Antonella Castagna, et al.
Open Forum Infectious Diseases|September 22, 2025
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART ProgramLucia Bailón, Yovaninna Alarcón-Soto, Angel Rivero, et al.
Cell Reports|May 12, 2021
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8<sup>+</sup> T cell antiviral responsesHongbing Yang, Anuska Llano, Samandhy Cedeño, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2008
Contribution of immunological and virological factors to extremely severe primary HIV type 1 infectionJudith Dalmau, Maria Carmen Puertas, Marta Azuara, et al.
AIDS (London, England)|November 9, 2021
Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategyJose A Muñoz-Moreno, Sara Carrillo-Molina, Ignacio Martínez-Zalacaín, et al.
Journal of Medical Virology|November 6, 2023
IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective studyDaniel Sepúlveda-Crespo, María A Jiménez-Sousa, Amanda Fernández-Rodíguez, et al.
Communications Medicine|December 8, 2025
Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._Lucia Bailón, Yovaninna Alarcón-Soto, José R Arribas, et al.
The Journal of Infectious Diseases|October 28, 2024
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral BloodLucía Bailón, Maria C Puertas, Maria C García-Guerrero, et al.
Pageof 10